Phatebo GmbH

Phatebo GmbH Overview

Phatebo GmbH is a pharmaceutical wholesaler based in Hilzingen, Baden-Württemberg. The company has a wholesale license in accordance with Section 52a AMG and supplies pharmacies, hospitals and other approved customers with medicines.

Leistungen & Belieferung

As a pharmaceutical wholesaler, Phatebo GmbH handles the storage, picking and distribution of medicines to pharmacies, hospitals and other authorized parties. The company works according to the EU guidelines for good sales practice (GDP).

Location & Contact

Phatebo GmbH can be reached at the following address: Gewerbestraße 21, 78247 Hilzingen – Phone: 077319212094. For current information and enquiries, please contact the company directly.

More information: Pharmagrosshandel in Baden-Württemberg or all Pharmagrosshandel in Germany on Sanoliste.

Pharmazeutischer Großhandel in Deutschland

Pharmaceutical wholesalers form the logistical backbone of pharmaceutical supply in Germany. Companies like Phatebo GmbH store, commission and distribute medicines to pharmacies, hospitals and other approved buyers. The approximately 100 wholesale locations in Germany supply over 18,000 pharmacies - often several times a day and within a few hours.

Regulierung & GDP-Konformität

Phatebo GmbH requires a wholesale license in accordance with Section 52a AMG and is subject to the EU guidelines on good sales practice (GDP). These regulate storage conditions, temperature monitoring, transport, traceability and the qualification of personnel. Regular inspections by the responsible state authorities ensure compliance. Since 2019, all prescription medicines have also had to be checked for authenticity using the securPharm system.

Versorgungssicherheit & Lieferketten

Wholesalers typically keep an inventory of several weeks in order to cushion delivery bottlenecks. Phatebo GmbH, based in Hilzingen, is part of this supply chain. In view of increasing global supply bottlenecks, the role of wholesalers as a buffer between manufacturers and pharmacies is becoming increasingly important. The Federal Institute for Medicines keeps a public register of current supply bottlenecks.